Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    savita thakur thakur
    savita thakur thakur
      • Home
      • savita thakur thakur

      Articles By : savita thakur thakur

      Alivira to take 70 pc in Interchange Brazil for 3.6 mn dollars

      Alivira to take 70 pc in Interchange Brazil for 3.6 mn dollars

      savita thakur thakur17 April 2016 1:48 PM IST
      New Delhi : Drug firm SeQuent Scientific has said its subsidiary Alivira Animal Health will acquire 70 per cent stake in Interchange Industria e...
      Advent and Baxter set to submit bids for Indias Gland Pharma

      Advent and Baxter set to submit bids for Indias Gland Pharma

      savita thakur thakur17 April 2016 1:48 PM IST
      Hong Kong : Global buyout firm Advent International and U.S. based Baxter International are among suitors preparing to submit separate bids to buy...
      Alkem Labs accused of fudging trial data by German regulator

      Alkem Labs accused of fudging trial data by German regulator

      savita thakur thakur16 April 2016 3:42 PM IST
      Mumbai : Alkem Laboratories has been accused by Germany's health regulator of fudging data on clinical trials of an antibiotic and brain disorder...
      Repros to drop testosterone drug in US if key study fails

      Repros to drop testosterone drug in US if key study fails

      savita thakur thakur16 April 2016 2:16 PM IST
      Amrutha Penumudi : Repros Therapeutics Inc will abandon efforts to seek approval for its testosterone drug in the United States if an ongoing study...
      Indian companies get USFDA nod for 14 1st-time generic drugs in 2015

      Indian companies get USFDA nod for 14 1st-time generic drugs in 2015

      savita thakur thakur16 April 2016 2:16 PM IST
      New Delhi : Indian pharma firms accounted for 14 of total 90 first-time generic drug approvals granted by the United States Food and Drug...
      WHO recommends Sanofis vaccine to control dengue spread

      WHO recommends Sanofis vaccine to control dengue spread

      savita thakur thakur16 April 2016 2:16 PM IST
      Paris : World Health Organisation's Strategic Advisory Group of Experts on Immunization (SAGE) has recommended the use of dengue vaccine developed by...
      Zota poised to Tap the Potential of its Patented Research- RTFIT

      Zota poised to Tap the Potential of its Patented Research- RTFIT

      savita thakur thakur15 April 2016 1:41 PM IST
      Surat: Zota Healthcare, a Surat based Indian multinational Pharma, has made its mind to put all-out efforts to make RTFIT a mega brand. After...
      Merck Says FDA Accepts Its SBLA For Keytruda For Treatment Of Head & Neck Cancer

      Merck Says FDA Accepts Its SBLA For Keytruda For Treatment Of Head & Neck Cancer

      savita thakur thakur15 April 2016 1:38 PM IST
      Merck & Co. Inc. (MRK), known as MSD outside the United States and Canada, Wednesday announced that the U.S. Food and Drug Administration has...
      Medtronic Insulin pumps shows benefits for type 2 diabetes

      Medtronic Insulin pumps shows benefits for type 2 diabetes

      savita thakur thakur15 April 2016 1:23 PM IST
      Dublin : Medtronic plc has announced the publication of new data in Diabetes, Obesity and Metabolism from the continuation phase of the OpT2mise...
      Quest Diagnostics launches test for picking hepatitis C drug

      Quest Diagnostics launches test for picking hepatitis C drug

      savita thakur thakur15 April 2016 1:07 PM IST
      Top testing company Quest Diagnostics has begun offering new hepatitis C tests that can help doctors determine which of the expensive new drugs for...
      Snap Fitness to open 240 clubs across India in next 3 years

      Snap Fitness to open 240 clubs across India in next 3 years

      savita thakur thakur14 April 2016 2:30 PM IST
      New Delhi : As part of its expansion plans, US-based fitness chain Snap Fitness is planning to open around 240 health clubs across the country in the...
      Cipla completes share allocation to FIL Capital Investments

      Cipla completes share allocation to FIL Capital Investments

      savita thakur thakur14 April 2016 2:25 PM IST
      New Delhi : Drug major Cipla said its arm Cipla Health has completed allocation of shares to FIL Capital Investments (Mauritius) II Ltd.Cipla had...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok